DON LYNN GIBBONS to Antibodies, Bispecific
This is a "connection" page, showing publications DON LYNN GIBBONS has written about Antibodies, Bispecific.
Connection Strength
0.169
-
Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC. J Thorac Oncol. 2024 03; 19(3):500-506.
Score: 0.169
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.